News Headlines

  1. Recipharm Partners With Sato To Manufacture Product For Japanese Market

    Recipharm, the contract development and manufacturing organisation (CDMO), has entered into a long term agreement with Sato Pharmaceutical Co. for the commercial manufacture and delivery of Emla Patch to Japan.

  2. PCI Clinical Services Announces Additional Cryogenic Storage Capacity At Its Rockford, IL Site

    Leading pharmaceutical outsourcing services provider PCI Clinical Services (PCI) has announced a second phase 400 percent increase in Cyrogenic storage capabilities at its Rockford, Illinois site.

  3. Hitachi Chemical Signs Agreement To Purchase From Caladrius Biosciences The Remaining 80.1% Interest in PCT For $75M

    Caladrius Biosciences, Inc. (“Caladrius” or the “Company”), a cell therapy company with a select therapeutic development pipeline focused on immune modulation, announces that the Company has signed a definitive agreement (the “Agreement”) in which its remaining 80.1% ownership interest in its PCT, LLC (“PCT”) subsidiary will be purchased by Hitachi Chemical Co. America, Ltd. (“Hitachi Chemical”) for $75M in cash; and in addition there is the potential for Caladrius to receive an additional cash payment of $5M if PCT achieves a certain revenue-based milestone.

  4. Contract Manufacturer Pfizer CentreOne Adds Highly Potent Solid Oral Dose To Its Service Portfolio

    Pfizer CentreOne, a global contract manufacturing organization (CMO) embedded within Pfizer, recently announced that it has grown its service portfolio to include contract manufacturing of highly potent solid oral dose medicines.

  5. Outsourced Pharma Boston Agenda Update

    utsourced Pharma Boston will feature Biogen as its Spotlight Leadership Company at its conference for professionals of biotech, pharma, and contract development and manufacturing organizations (April 26 -27 at the Boston Park Plaza). The session is titled: Manufacturing Strategy: How Biogen Positions Outsourcing & Partnering as a Foundational Element of Its Network.

  6. President Donald J. Trump Announces Key Administration Post

    President Donald J. Trump recently announced his intent to nominate Scott Gottlieb of Connecticut, to be Commissioner of Food and Drugs at the Department of Health and Human Services, vice Robert McKinnon Califf.

  7. Clinical Leader Forum Announces Panelist Update

    Clinical Leader announces agenda and panelist updates for its Clinical Leader Forum to be held in Philadelphia on May 10 – 11 at the Hilton Philadelphia City Avenue. Clinical Leader Forum is a conference designed for executives at pharma and biotech sponsor companies who rely on contract research organizations to conduct their clinical trials.

  8. Mutual Recognition Promises New Framework For Pharmaceutical Inspections For United States And European Union

    The United States and the European Union (EU) completed an exchange of letters to amend the Pharmaceutical Annex to the 1998 U.S.-EU Mutual Recognition Agreement.

  9. Bushu And Takeda Announce Transformational Pharmaceutical Sciences Partnership

    Bushu Pharmaceuticals Limited and Takeda Pharmaceutical Company Limited  announced recently that the companies have entered into a new partnership agreement under which Takeda will transfer a part of its Pharmaceutical Sciences/CMC business to Bushu.

  10. Sanofi And Lonza Enter Into A Strategic Partnership To Establish A Large-Scale Biologics Production Facility

    Sanofi and Lonza announced recently that they have entered into a strategic partnership to build and operate a large-scale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland.